What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Adrian L. Harris mainly investigates Cancer research, Pathology, Angiogenesis, Internal medicine and Breast cancer.
Adrian L. Harris has researched Cancer research in several fields, including Hypoxia, Hypoxia-inducible factors, Gene expression, Transcription factor and Regulation of gene expression.
His studies in Pathology integrate themes in fields like Cancer and Growth factor.
His Angiogenesis research includes themes of Vascular endothelial growth factor A, Vascular endothelial growth factor and Metastasis.
His Internal medicine research includes elements of Endocrinology and Oncology.
His Breast cancer research is multidisciplinary, incorporating perspectives in Proportional hazards model, Surgery, Macrophage and Gene expression profiling.
His most cited work include:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Hypoxia — a key regulatory factor in tumour growth (3783 citations)
- Guidelines for the use and interpretation of assays for monitoring autophagy (3242 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Cancer research, Internal medicine, Pathology, Angiogenesis and Breast cancer.
His Cancer research research is multidisciplinary, incorporating elements of Hypoxia, Hypoxia-inducible factors, Gene expression, Cancer cell and Immunology.
His research in Hypoxia focuses on subjects like Cell biology, which are connected to Transcription factor.
His research integrates issues of Gastroenterology, Endocrinology and Oncology in his study of Internal medicine.
His Angiogenesis research incorporates themes from Vascular endothelial growth factor A, Vascular endothelial growth factor, Metastasis and Endothelial stem cell.
His work on Breast cancer is being expanded to include thematically relevant topics such as Gene expression profiling.
He most often published in these fields:
- Cancer research (36.07%)
- Internal medicine (29.95%)
- Pathology (24.80%)
What were the highlights of his more recent work (between 2014-2021)?
- Cancer research (36.07%)
- Breast cancer (21.26%)
- Cancer cell (8.45%)
In recent papers he was focusing on the following fields of study:
Adrian L. Harris focuses on Cancer research, Breast cancer, Cancer cell, Cancer and Internal medicine.
His research in Cancer research is mostly concerned with Angiogenesis.
His work in Angiogenesis tackles topics such as Pathology which are related to areas like Ductal carcinoma.
His work focuses on many connections between Breast cancer and other disciplines, such as Metformin, that overlap with his field of interest in Flux and Metabolomics.
His Cancer cell research incorporates elements of Cell, Cell growth, Molecular medicine, Glycolysis and Tumor microenvironment.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Oncology.
Between 2014 and 2021, his most popular works were:
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (4170 citations)
- Imaging biomarker roadmap for cancer studies. (407 citations)
- Antiangiogenic therapy in oncology: current status and future directions. (393 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Adrian L. Harris mainly focuses on Cancer research, Cancer cell, Cell biology, Breast cancer and Angiogenesis.
His Cancer research study combines topics in areas such as Hypoxia, Gene expression profiling, Transcriptome, Downregulation and upregulation and Metabolomics.
His Cancer cell research is classified as research in Internal medicine.
His research in Breast cancer intersects with topics in Carbonic Anhydrase IX, Clinical trial, Pathology and Estrogen.
In general Pathology study, his work on Carcinoma often relates to the realm of Accreditation, thereby connecting several areas of interest.
Adrian L. Harris combines subjects such as Vascular endothelial growth factor A, Metastasis and Combination therapy with his study of Angiogenesis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
